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The use of naturally-occurring agents to regulate tumorigenesis is on the rise. Several herbal extracts,
pure plant-derived active constituents, and food additives have been reported to possess potent anti-
cancer properties and cancer-ameliorating effects. The wide-range anti-cancer effects of Nigella sativa,
also known as black seed or black cumin, have been extensively studied using different in vitro and
in vivo models. Here, we provide a comprehensive, analytical review of the reported anti-cancer prop-
erties of N. sativa seed extracts. This review focuses on analyzing experimental ﬁndings related to the
ability of N. sativa to exert anti-proliferative, pro-apoptotic, anti-oxidant, cytotoxic, anti-mutagenic, anti-
metastatic, and NK cytotoxic activity enhancing effects against various primary cancer cells and cancer
cell lines. Moreover, we underline the molecular mechanisms of action and the signal transduction
pathways implicated in the suppression of tumorigenesis by N. sativa. The major signaling pathway
utilized by N. sativa to manifest its anti-cancer activity is the iNOS signaling pathway. This review un-
derscores the recent developments that highlight an effective therapeutic potential of N. sativa to sup-
press tumor development, reduce tumor incidence, and ameliorate carcinogenesis. In sum, experimental
ﬁndings reported in the last two decades strongly suggest that N. sativa fractions could serve, alone or in
combination with known chemotherapeutic drugs, as effective agents to control tumor initiation,
growth, and metastasis, and hence, treatment of a wide range of cancers.
© 2016 Transdisciplinary University, Bangalore and World Ayurveda Foundation. Publishing Services by
Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).1. Introduction
Many herbs have been shown to possess therapeutic potential
towards several medical conditions, and hence, they are of a sub-
stantial medicinal value. For centuries, people around the globe
have been using numerous medicinal herbs to alleviate the signs
and symptoms of various disorders [1]. Herbal medicine, also
known as botanical medicine, phytomedicine, phytotherapy, her-
bology, and herbalism, is a form of therapy that uses plants or plant
extracts to prevent or treat different diseases and to boost the
overall health status [1]. Herbal medicine is one of the oldest, if not
the oldest, and probably remains to be of growing popularity. It is
really intriguing that despite the great advancement in the ﬁelds of
conventional medicine and drug discovery, the use of herbalalawieh).
ary University, Bangalore.
alore and World Ayurveda Found
icenses/by-nc-nd/4.0/).formulations is still extremely widespread throughout the world,
indicative of peoples' perception of the safety and therapeutic ef-
ﬁcacy of such medicinal herbs. Although herbal medicine is more
prevalent in Asia, Africa, and to a lesser extent in Europe, the use of
medicinal herbs has witnessed a signiﬁcant, gradual increase in
North America [1,2]. It is most likely the gentle, nourishing, efﬁ-
cacious, synergistic, cost-effective, and safe properties of medicinal
herbs that make them an attractive option for many people as
therapeutic agents [1,2]. In fact, the discovery of the vast majority, if
not all, conventional drugs is based on the chemical, physiological,
and therapeutic actions of the bioactive constituents of many me-
dicinal herbs. The recent advancement in pharma and medicine,
manifested by the development of biotechnologies, and mass
production of highly speciﬁc, chemically-synthesized drugs, has
certainly revolutionized the therapeutic approach to health care
and disease management worldwide. However, herbal medicine
continues to be a primary ideology in many populations today and
a very common practice in different parts of the world.ation. Publishing Services by Elsevier B.V. This is an open access article under the
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most cuisines, primarily used as a source of ﬂavor and aroma.
Besides their use as food additives, a wide range of herbs and
spices have been used to prevent or treat medical conditions
including cancer. Over the past few decades, research investigating
dietary factors and their effects on various medical conditions has
been constantly growing. A large number of studies focused on
these naturally-occurring products and reported a plethora of
anti-cancer properties manifested through various molecular
mechanisms. For instance, an ethanolic extract of Piper nigrum
(black pepper) has been shown to induce DNA damage and reduce
cell viability in MCF-7 human cancer cells [3]. Treatment with the
ethanolic extract of P. nigrum inhibited cell proliferation by 57%
and elevated ROS levels by 65%. Moreover, the same extract
increased Bax and p53 levels, both of which are key proteins in
regulating the cell cycle arrest. Another study used ﬂow cyto-
metric analysis to describe the anti-cancer effects exerted by
Fagonia cretica, a tea herb and a food additive [4]. Indeed, the F.
cretica extract caused a dose-dependent arrest of the cell cycle at
G0/G1 phase and enhanced the rate of apoptosis in MCF-7 and
MDA-MB-231 human cancer cells. Another example of a widely
used active food constituent is sesamin, a major lignin in sesame
seeds. Siao and colleagues showed that sasamin plays a strong
preventive role against cancer by modulating apoptotic signaling
pathways and restricting angiogenesis [5]. Hence, various herbs
and food additives are becoming widely used for the treatment
and/or the prevention of acute and chronic conditions ranging
from mild allergies to more serious diseases including cancer. Yet,
despite the intensive research efforts devoted to the identiﬁcation
of herbs with therapeutic properties, the exact molecular path-
ways and cellular mechanisms by which these herbs induce their
therapeutic effects are not fully understood.
Nigella sativa is an annual ﬂowering plant that is grown almost
all over the world but is native to South and Southwest Asia and
commonly found in Northern Africa, the Middle East, and Southern
Europe [6,7]. N. sativa is also known as nigella, blackseed, black
cumin, black caraway, Roman coriander, fennel ﬂower, nutmeg
ﬂower, “kalonji” (in India), “Kalo jeera” (in Bangladesh), “Hak Jung
Chou” (in China), and “habbat al-barakah” (in the Middle East).
N. sativa belongs to the botanical family Ranunculaceae [8,9]. The
mature plant grows to 20e90 cm of height with ﬁnely divided
leaves, and white, pale blue, or pale purple delicate ﬂowers con-
taining 5e10 petals [10]. The follicles within the fruits containmany
small (2.0e3.5mm  1.0e2.0 mm) angular, black seeds with
whitish interior [10]. Aside from its use as a food ﬂavoring additive,
N. sativa seeds oil and extracts have been used since ancient times
to treat several diseases and medical conditions. N. sativa plant
extracts have been commonly used in various traditional systems of
medicine like Ayurveda, Siddha, Unani, Arabic, Islamic, etc. Several
N. sativa crude extracts have been popularly used in traditional
medicine as appetite stimulants, bronchodilators, liver tonics, and
analgesics as well as to treat various conditions like diabetes,
asthma, hypertension, cardiovascular disease, liver and kidney
diseases, digestive problems, diarrhea, skin disorders, microbial
infections, cancer, etc. [7e19] Such uses of N. sativa extracts in
traditional medicine have been validated by well-designed exper-
iments showing that such extracts possess cardio-protective, anti-
microbial, anti-histaminic, anti-diabetic, antihypertensive, anti-
hyperlipidemic, anti-diarrheal, hepato-protective, renal protec-
tive, gastro-protective, spasmolytic, immunomodulatory, anti-
inﬂammatory, anti-oxidant, and anti-cancer properties [7e19].
Hence, traditional medicine uses that are validated by experimental
evidence strongly suggest that N. sativa extracts can be of potent
therapeutic efﬁcacy in the prevention and treatment of various
infectious and non-infectious diseases.In this review, the in vitro and in vivo anti-cancer properties of
N. sativa extracts are discussed. Special emphasis is given to the
molecular and cellular mechanisms that mediate the anti-
proliferative, pro-apoptotic, and anti-oxidant effects of N. sativa.
Recent advances in the establishment of an effective therapeutic
potential of N. sativa extracts, leading to suppressed tumor initia-
tion and progression, are also underscored.
2. Anti-proliferative and pro-apoptotic effects of N. sativa
The potent anti-cancer potential of N. sativa is well established
through in vitro and in vivo studies using different cell lines and
animal models. Driven by traditional medical practices in Sri Lanka,
a decoction (hot-water extract) comprised of N. sativa (seeds),
Hemidesmus indicus (roots), and Smilax glabra (rhizome), a poly-
herbal mixture used to treat different types of cancer, has been
shown to ameliorate diethylnitrosamine-induced hepatocarcino-
genesis in maleWistar rats at a dose of 4e6 g/kg/day after 10 weeks
of oral feeding [20]. The researchers of the aforementioned study
indicated that the potential anti-cancer effects of the extracts of the
individual plants in the decoction were not examined because only
the decoction is traditionally used in cancer chemotherapy [20].
Subsequent studies suggest that ﬂow cytometric analysis con-
ducted using Annexin V and propidium iodide staining demon-
strated that HepG2 cells were in the late stage of apoptosis and/or
necrosis 24 h post treatment with the polyherbal mixture [21].
Consistently, oral administration (6 g/kg/day) of the polyherbal
mixture of N. sativa, H. indicus, and S. glabra led to a long-term
protection against diethylnitrosamine-induced hepatocellular ad-
enoma in Wistar rats [22,23]. In fact, a great deal of literature un-
derscores many in vitro and in vivo effects of pure N. sativa extracts.
In an early in vivo study, topical application of N. sativa extract
(100 mg/kg) inhibited the two-stage initiation/promotion of skin
carcinogenesis and delayed the onset of skin papilloma in mice
challenged with 7,12-dimethylbenzanthracene/croton oil [24]. The
same study revealed that intraperitoneal administration of N. sativa
extract signiﬁcantly reduced methylcholanthrene (MCA)-induced
soft tissue sarcomas in albino mice by about 70% following 30 days
of subcutaneous administration of MCA [25]. Aqueous and etha-
nolic extracts ofN. sativa seeds, both separately and in combination,
were shown to exert potent anti-proliferative effects on MCF-7
human breast cancer cells in presence and absence of H2O2,
which seems to play a synergistic role [26]. In another study, Salim
and Fukushima examined the effects of N. sativa oil on the devel-
opment of colon tumors in a murine model of 1,2-
dimethylhydrazine (DMH)-induced colon cancer [27]. Fourteen
weeks post DMH challenge, Fischer 344 rats that were treated with
N. sativa oil at the initiation and post-initiation stages of colon
carcinogenesis displayed signiﬁcantly reduced DMH-induced
aberrant crypt foci (ACF), which are putative pre-neoplastic le-
sions for colon cancer [27]. Immunohistochemical analysis revealed
that N. sativa oil exerted potent anti-proliferative activity in the
colonic ACF in rats that were treated with N. sativa oil at both the
initiation and post-initiation stages of DMH challenge [27]. Simi-
larly, using 7,12-di-methylbenz(a)anthracene (DMBA)-induced
mammary carcinoma model, female SpragueeDawley rats that
were injected with DMBA were subsequently orally treated with
N. sativa oil (4 g/kg/day) starting 2 weeks before or at the time of
DMBA injection, and the experiment lasted for 3 months [28]. The
frequency of mammary papillary, comedo, and cribriform carci-
noma was reduced in rats treated with N. sativa oil at the time of
DMBA injection, and this frequency was more potently recused in
rats that were pre-treated with N. sativa oil for 2 weeks before
DMBA challenge [28]. The reduced frequency of mammary carci-
noma was associated with reduced serum levels of tumorigenicity
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serum levels of endocrine derangement markers (prolactin, estra-
diol, and progesterone) and levels of apoptotic markers (serum
tumor necrosis factor a (TNFa), tissue caspase-3 activity, and DNA
fragmentation) [28]. Using the essential oil, an ethanolic extract,
and a butanol extract of N. sativa and different cell lines (P815, IC01,
Vero cells, and BSR cells), Ait Mbarek and colleagues demonstrated
that the potency of the in vitro anti-cancer activity of N. sativa de-
pends, at least partially, on the tumor cell type [29]. In the afore-
mentioned study, the anti-cancer activity of N. sativa essential oil
was also evaluated in vivo. Injection of 30e50 ml (28.5e47.5 mg/
mouse) N. sativa essential oil into the tumor site of a DBA2/P815
(H2d) mouse model led to a signiﬁcant suppression of solid tumor
development (more than 10-fold decrease in tumor size) and
resulted in a signiﬁcantly delayed mortality of P815 mastocytoma
tumor-bearing mice [29]. Recently, the administration of N. sativa
ethanolic extract treatment was shown to improve the histopath-
ological changes in themalignant liver tissuewhich were caused by
diethylnitrosamine (DENA) treatment, without causing any direct
cytotoxic effect [30]. In a similar study, the effects of a methanolic
extract of N. sativa on the modulation of glyco-regulatory enzymes
in an albino rat model of hepatocellular carcinoma were investi-
gated [31]. Hepatocellular carcinoma was induced in albino rats by
intraperitoneal injection of DENA and carbon tetrachloride (CCl4),
leading to a signiﬁcant increase in the serum level of a-fetoprotein
(AFP), the relative liver weight, and the activities of hexokinase,
glyceraldehyde phosphate dehydrogenase, and G6P dehydrogenase
in both the serum and liver homogenate of treated rats. Oral
administration of a methanolic extract of N. sativa (1 g/kg/day) for 2
weeks prior to induction of hepatocellular carcinogenesis improved
the histopathological changes associated with DENA and CCl4
treatment, bringing the physiological and biochemical parameters
indicated above back to normal levels [31]. Very recently, an in vitro
study demonstrated that an aqueous extract of N. sativa (0.1e1.0%
concentration) caused a signiﬁcant decrease in cell proliferation
and varying morphological changes including cell shrinkage and
membrane damage in HepG2 cells, accompanied by DNA damage
and cell death [32] (Fig. 1).Fig. 1. A brief summary of the known molecular and cellular mechanisms underlying the an
and NK-mediated cytotoxic effects of N. sativa. (TSA: total sialic acid, LSA: lipid-bound sia
malondialdehyde, NO: nitric oxide, ROS, reactive oxygen species, GSH: glutathione, t-PA: t
plasminogen activator inhibitor type 1, IFNg: interferon g).3. Anti-oxidant and cytotoxic effects of N. sativa
Among the ﬁrst reports pointing to the potential anti-cancer
properties of N. sativa, Swamy and Tan demonstrated that an
aqueous extract and an ethyl acetate chromatographic fraction of
N. sativa seeds (50 mg/ml) caused signiﬁcant cytotoxic effects
against various types of cancer cell lines (HepG2, MOLT4, and LL/
2), but not against normal, non-cancerous human umbilical cord
endothelial cells [33]. Aside from their anti-proliferative effects,
both aqueous as well as ethanolic extracts of N. sativa seeds were
found to induce signiﬁcant cytotoxic effects on MCF-7 cells in
presence and absence of H2O2 [26]. However, the ethanolic extract
of N. sativa exerted more potency against MCF-7 cells compared to
the aqueous extract (LC50 values in presence of H2O2 were 377 mM
and 725 mM, respectively). Also, the aforementioned anti-cancer
polyherbal mixture, which is comprised of N. sativa (seeds),
H. indicus (roots), and S. glabra (rhizome), was shown to exert
cytotoxic effects in human hepatoma HepG2 cell line at 5e50 mg/
ml concentration [21]. In fact, the three individual plant extracts
exerted cytotoxic efﬁcacy in the order N. sativa >
H. indicus > S. glabra [21]. Such anti-cancer effects were conﬁrmed
by Samarakoon and colleagues who demonstrated that both the
aqueous and ethanolic extracts of the polyherbal mixture of
N. sativa, H. indicus, and S. glabra caused strong dose-dependent
cytotoxicity in HepG2 cells [22]. However, most of these studies
do not yield insightful results since N. sativa extracts were used in
combination with H. indicus and S. glabra extracts, making it
challenging to draw plausible conclusions regarding the anti-
cancer activity of N. sativa itself. Nonetheless, several studies
examined the effects of N. sativa and its extracts on various cell
lines. An in vitro cytotoxic study showed that a crude methanolic
extract of N. sativa caused about 50% cytotoxicity in Ehrlich ascites
carcinoma (EAC), Dalton's lymphoma ascites (DLA), and Sarcoma-
180 cells (S-180 cells) [24]. Another in vivo study demonstrated
that 6-month oral administration of N. sativa seeds (0.2 g/rat/day)
provided protective effects against methylnitrosourea-induced
oxidative stress and colon carcinogenesis in Sprague Dawely rats
due to reduced expression of malondialdehyde (MDA), ati-proliferative, pro-apoptotic, anti-oxidant, cytotoxic, anti-mutagenic, anti-metastatic,
lic acid, AFP: a-fetoprotein, TNFa: tumor necrosis factor a, IL-6: interleukin-6, MDA:
issue-type plasminogen activator, u-PA: urokinase-type plasminogen activator, PAI-1:
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and colleagues examined the possible biochemical and histo-
pathological effects of N. sativa ﬁxed oil in Iops of a mice and
Wistar-Kyoto rats [35]. Acute toxicity of N. sativa ﬁxed oil was
assessed in mice that received a single oral or intraperitoneal dose,
and the LD50 values were determined to be 28.8 ml/kg and
2.06 ml/kg, respectively [35]. The chronic toxicity of N. sativa ﬁxed
oil was assessed in rats receiving a daily oral dose of 2 ml/kg for a
period of 12 weeks. It was demonstrated that chronic treatment
with N. sativa ﬁxed oil did not affect the level or catalytic activity of
key hepatic enzymes including aspartate-aminotransferase,
alanine-aminotransferase, and gamma-glutamyltransferase, nor
it had any marked histopathological effects in the heart, liver,
kidney, and pancreatic tissues [35]. The very low toxicity of the
chronic treatment with N. sativa ﬁxed oil was evidenced by
biochemical stability and high LD50 values, suggesting that the
indicated doses are sub-toxic and do not raise major safety con-
cerns. Moreover, Islam and colleagues demonstrated that N. sativa
oil exerts cytotoxic effects against a panel of four human cancer
cell lines (SCL, SCL-6, SCL-3706, and NUGC-4) and 3T6 ﬁbroblast
mouse cell line with LC50 values 155.02 ± 10.4, 185.77 ± 2.9,
120.40 ± 20.5, 384.53 ± 12.1, and 286.83 ± 23.3 mg/ml, respectively,
with no signiﬁcant cytotoxic effects on normal cells [36]. In
another study, Ali assessed the ability of N. sativa oil to ameliorate
the nephrotoxicity associated with gentamicin, an antibiotic, in
rats [37]. Intramuscular injection of gentamicin was associated
with proximal tubular damage, histopathological and biochemical
signs of nephrotoxicity, elevated levels of creatinine and urea, as
well as decreased level of glutathione (GSH) and total anti-oxidant
status [37]. Such effects were abrogated by oral administration of
N. sativa oil (1e2 ml/kg/day) for 10 days, without any detectable
overall toxicity [37]. Similarly, oral N. sativa treatment (4 g/kg/day)
of rats with DMBA-induced mammary carcinoma for a period of 3
months resulted in reduced tissue levels of oxidative stress
markers (NO and lipid peroxides) [28]. Intragastric administration
of N. sativa oil for 12 days in male albino rats potently reduced the
hepatic and overall toxic effects associated with intraperitoneal
administration of cyclophosphamide, an anti-cancer drug that
causes a high degree of lipid peroxidation and reactive oxygen
species (ROS) over-production [38]. Similarly, oral administration
of N. sativa oil (90 mg/kg/day) in albino rats for 30 and 60 days
signiﬁcantly ameliorated, in a time-dependent manner, the toxic
effects and pathological tissue damage in the spleen and thymus
resulting from treatment with chloramphenicol, a potent anti-
biotic [39]. These ﬁndings suggest that N. sativa oil co-treatment
could potentially reduce the toxicity-related side effects that
accompany the bactericidal and anti-cancer chemotherapy. In a
recent study, the hepatotoxic effects of N. sativawere evaluated in
Spargue Dawley rats bymeasuring the catalytic activity of key liver
enzymes (ALT and AST) and by histopathological assessment of
liver tissue [40]. Rats were fed diet supplemented with 0.01e1 g/
kg/day of N. sativa seeds powder for 28 days. It was demonstrated
that N. sativa powder supplementation did not lead to a signiﬁcant
change in the catalytic activity of ALT and AST, histopathological
abnormalities, inﬂammation, or necrosis in the liver tissue even at
the highest dose of 1 g/kg/day [40]. This study showed that
0.01e1 g/kg/day doses of N. sativa seeds powder caused no marked
toxic effects on liver function in rats and they are considered safe.
Very recently, Hadi and colleagues performed a clinical trial to
assess the anti-oxidant effects of N. sativa oil in patients with
rheumatoid arthritis (RA) [41]. It was revealed that a daily dose of
1 g N. sativa oil for 8 weeks signiﬁcantly reduced the serum levels
of MDA and NO, suggesting that N. sativa can potentially be
employed in the treatment of RA due to its ability to suppress RA-
associated oxidative stress responses [41] (Fig. 1).4. Anti-mutagenic effects of N. sativa
A few studies have examined the potential of N. sativa to exert
anti-mutagenic activity against N-methyl-N0-nitro-N-nitro-
soguanidine (MNNG), a directly acting mutagen. Although an
aqueous extract of N. sativa had no cytoprotective nor anti-
mutagenic activity against MMNG in primary rat hepatocytes
[42], an ethanolic extract of N. sativa exerted an inhibitory effect
against MNNG mutagenicity due to signiﬁcantly reduced chromo-
somal aberrations in primary rat hepatocytes [43]. The anti-
mutagenic activity of the ethanolic extract of N. sativa was
observed in MNNG-challenged primary rat hepatocytes that were
pre-treated, co-treated, or post-treated with the extract, without
inducing direct apoptosis [43]. Such anti-mutagenic effects against
MNNG were attributed to possible induction of detoxifying en-
zymes that degradeMNNG, chemical interactionwith or absorption
of MNNG (or its electrophilic degradation products), enhanced ﬁ-
delity of DNA replication, and/or improved DNA repair [43]. Such
factors that prevent or reduce chromosomal aberrations [43].
Although some ﬁndings provide evidence of a potent anti-
mutagenic activity of N. sativa, research is still in its early stages
of establishing a direct link between the speciﬁc ingredients in
N. sativa extracts and the anti-mutagenic activity ofN. sativa (Fig.1).
5. Anti-metastatic effects of N. sativa
Awad investigated the effect of N. sativa oil on HT1080 human
ﬁbrosarcoma cell lines with regard to their ﬁbrinolytic potential, a
hallmark of malignant tumors [44]. N. sativa oil (25e200 mg oil/ml)
caused a signiﬁcant dose-dependent down-regulation of key
ﬁbrinolytic products including tissue-type plasminogen activator
(t-PA), urokinase-type plasminogen activator (u-PA), and plasmin-
ogen activator inhibitor type 1 (PAI-1), both in sub-conﬂuent and
conﬂuent cell cultures [44]. This study highlights the ability of
N. sativa to hinder local tumor invasion and metastasis. Ait Mbarek
and colleagues reported similar ﬁndings, whereby injection of
30e50 ml (28.5e47.5 mg/mouse) N. sativa essential oil into the tu-
mor site of a DBA2/P815 (H2d) mouse model resulted in inhibition
of liver metastasis even after 30 days of treatment [29] (Fig. 1).
6. Effects of N. sativa on natural killer (NK) cytotoxic activity
Enhancement of NK cytotoxic activity has been proposed by
several research groups to serve as a mechanism underlying the
anti-cancer effects of N. sativa [45e50]. In an in vivo study per-
formed on healthy volunteers, El-Kadi and colleagues showed that
ingestion of N. sativa oil for 4 weeks enhanced the ratio of helper to
suppressor T cells and signiﬁcantly improved NK cytotoxic func-
tion [46]. In agreement, an in vivo study performed in mice
revealed that 1-week oral administration of an aqueous extract of
N. sativa caused a signiﬁcant increase in the number of splenic NK
cells and a signiﬁcant enhancement of splenic NK cytotoxic ac-
tivity against YAC-1 tumor cells [48]. These in vivo ﬁndings were
supported by in vitro studies. Abuharfeil and colleagues demon-
strated that a fresh aqueous extract of N. sativa (50 and 100 mg/ml)
led to a signiﬁcant increase in splenic NK cytotoxic activity against
YAC-1 tumor cells (% cytotoxicity 43.7 ± 3.6 and 62.7 ± 5.6 at
200:1 E:T ratio, 45.7 ± 5.7 and 44.6 ± 6.2 at 100:1 E:T ratio, and
13.6 ± 2.7 and 18.3 ± 3.1 at 50:1 E:T ratio, respectively) [47].
Indeed, the fresh aqueous extract of N. sativa appeared to be more
potent in inducing NK cytotoxic activity compared to the old dried
aqueous extract or the ethanolic extract [47]. A similar study from
our laboratory provided further in vitro experimental evidence
indicating that an aqueous extract of N. sativa (50e100 mg/ml)
signiﬁcantly enhanced killing of YAC-1 tumor cells due to
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(4.5 folds) cytotoxicity 200:1 E:T ratio at 50 mg/ml and 100 mg/ml
concentrations, respectively [50]. Importantly, enhanced killing of
YAC-1 tumor cells is due to the ability of N. sativa extract to
improve NK cytotoxic activity rather than inducing an immediate
cytotoxic effect. This is evidenced by the ﬁndings that N. sativa
extract had no signiﬁcant, direct cytotoxic effect against YAC-1
tumor cells in absence of NK cells [50]. We have reported similar
observations in which aqueous extracts (100 mg/ml) of black
pepper (P. nigrum) and cardamom (Elettaria cardamomum) caused
a signiﬁcant increase (35% and 45% cytotoxicity, respectively) in
the NK cytotoxic activity against YAC-1 tumor cells [51]. Therefore,
it seems that boosting the cytotoxic potential of NK cells against
tumor cells is at least one mechanism exploited by several plant
extracts to exert their tumoricidal action. Interestingly, Abuharfeil
and colleagues assessed NK cytotoxic activity in the presence of
the aqueous extract of N. sativa using splenocytes obtained from
BALB/c mice [47], whereas in our study the NK cytotoxic activity
was assessed using splenocytes obtained from C57/BL6 mice [50].
Although the enhancement of NK cytotoxic activity caused by
N. sativa does not seem to be strain-speciﬁc, more studies are
required to conﬁrm this argument using splenocytes from a wide
range of mice strains and even different animal models. Along the
same lines, an aqueous extract of N. sativa (10e500 mg/ml) was
shown to signiﬁcantly enhance the cytotoxic activity (26.6e67.7%
cytotoxicity) of NK cells isolated from human blood against K562
tumor cells in vitro [49]. The improved cytotoxic potential of NK
cells was primarily due to the ability of N. sativa extract to
signiﬁcantly enhance the production of interferon g (IFNg) and
TNFa, immunostimulatory cytokines with potent tumoricidal ac-
tivity, from NK cells [49]. Moreover, treatment of NK cells with
N. sativa extract led to a signiﬁcant increase in the release, and
hence activity, of granzyme A and N-acetyl-b-D-glucosaminidase,
key proteolytic enzymes involved in target cell killing [49]. These
ﬁndings suggest that augmentation of NK cytotoxic activity
against tumor cells serves as an effective immunomodulatory
mechanism that may explain, at least partially, the reported
in vitro and in vivo anti-cancer effects of N. sativa. An early in vivo
study, however, demonstrated that intraperitoneal injection of
N. sativa oil (100 mg/100 ml/mouse) for 7 days caused a signiﬁcant
decrease in the number of splenic NK cells in non-infected and
CMV-infected BALB/c mice [52]. Interestingly, although N. sativa
oil treatment had no effect on NK cytotoxic activity in non-infected
mice, it caused a signiﬁcant suppression of NK cytotoxic activity in
CMV-infected mice [52]. The same study revealed that in vitro
treatment of splenic NK cells isolated from non-infected mice with
N. sativa oil (100 mg/ml) signiﬁcantly decreased their cytotoxic
activity against YAC-1 tumor cells [52]. These ﬁndings are incon-
sistent with those reported by El-Kadi and his colleagues [46]
regarding the effects of N. sativa oil on NK cytotoxic effects
against cancer cells. These inconsistent ﬁndings are most likely
due to different experimental conditions including the dose of
N. sativa extract or oil, cell type, species, incubation time, and
method of detection. It is worth mentioning that N. sativa oil may
exert toxic effects against NK cells, which could be another factor
inﬂuencing the outcome of the reported experiments. Future
studies, with a carefully-designed experimental approach that
addresses the raised possible experimental variables, are required
to shed more light on the potential modulatory effects of N. sativa
oil on NK cytotoxic activity.
Although some of the signalingmolecules involved inmediating
the immunostimulatory effects of N. sativa extracts in NK cells have
been identiﬁed, the exact signaling pathways andmolecular targets
implicated in these pathways are largely unknown. Future in vitro
and in vivo studies should focus on elucidating the targetedreceptors and intracellular/extracellular factors involved in the
signal transduction pathways that are modulated in NK cells by
N. sativa extracts. Furthermore, we suggest that the stimulatory
potential of N. sativa toward NK cytotoxic activity be further
conﬁrmed by in vitro and in vivo studies using a wide range of
primary and transformed NK cells against numerous primary tu-
mors and cancer cell lines (Fig. 1).7. Signaling pathways underlying the anti-cancer effects of
N. sativa
Several in vitro and in vivo studies were conducted in an attempt
to elucidate the molecular and cellular mechanisms underlying the
anti-cancer activity of N. sativa. The key mechanisms underlying
the documented anti-cancer effects of N. sativa have been largely
attributed to their ability to modulate the activity of key enzymes
[31,43,44,49,53e58]. suppress inﬂammation [8,50,53,55,59e82],
and induce apoptosis in tumor cells [21,41,54,55,72,83e101].
Onemechanism that is implicated in tumorigenesis involves the
inducible nitric oxide synthase (iNOS) pathway. NO, which is syn-
thesized by iNOS or other nitric oxide synthase (NOS) isoforms
during physiological reactions including inﬂammation, is an
endogenous radical implicated in predisposition to tumor devel-
opment. In a recent study, Fathy and Nikaido investigated the effect
of an ethanolic extract of N. sativa onmodulating the iNOS pathway
in rats with DENA-induced hepatocarcinogenesis [30]. Oral
administration of N. sativa ethanolic extract (250 mg/kg/day) for 5
days led to a signiﬁcant reduction in the serum levels of AFP, NO,
interleukin-6 (IL-6), and TNFa, factors whose production was
signiﬁcantly increased after treatment with DENA [30]. Very
recently, Alhamzi and colleagues demonstrated that a methanolic
extract of N. sativa seeds (50e100 ml/ml) induced apoptosis in MCF-
7 cells in a time- and dose- dependent manner, as judged by TUNEL
assay [97]. The methanolic extract of N. sativa led to a signiﬁcant
time- and dose-dependent increase in the expression of apoptotic
factors including caspase-3, caspase-8, caspase-9, and p53 in MCF-
7 cells, indicating that N. sativamanifests its anti-cancer activity by
targeting the p53 and caspase signaling pathways [97].
A brief summary about the reported in vitro and in vivo anti-
cancer activities of N. sativa is given in Table 1.8. Anti-cancer effects of N. sativa phytoconstituents
Many of the anti-cancer activities of N. sativa have been attrib-
uted to its major active constituent, thymoquinone (TQ). TQ has
been shown to exert anti-proliferative, pro-apoptotic, anti-oxidant,
anti-oxidant, anti-mutagenic, anti-angiogenic, and anti-metastatic
effects against cancer cells [6,12,14,16e19,38,53,55,63,64,
66,70,71,77,82e100]. TQ seems to mediate its anti-cancer effects
by targeting a number of cellular pathways involving p53, NF-kB,
PPARg, STAT3, MAPK, and PI3K/AKT transducing signals
[67,69,72,83e100]. Besides TQ, other phytoconstituents of N. sativa
have also been shown to contribute to the anti-cancer potential of
N. sativa extracts. a-hederin is a pentacyclic triterpene saponin
found in N. sativa seeds that exerts effective anti-cancer effects,
both in vitro and in vivo [54,102e107]. Moreover, thymol, thymo-
hydroquinone, dithymoquinone, nigellimine-N-oxide, nigellicine,
nigellidine, and carvacrol are phytoconstituents of N. sativa that
have been demonstrated to play anti-cancer and cytotoxic func-
tions [13,108e117]. Yet, the exact molecular mechanisms underly-
ing the anti-cancer effects of these phytoconstituents are not fully
known, and future studies are needed to elucidate the detailed
mechanisms of action that mediate the anti-cancer effects of
N. sativa phytoconstituents.
Table 1
A brief summary of the reported in vitro and in vivo anti-cancer activities of N. sativa.
Activity N. sativa
Anti-proliferative and pro-apoptotic
effects
 Stimulation of anti-proliferative effects on MCF-7 cells [26].
 Reduction in frequency of mammary papillary, comedo, and cribriform carcinoma in DMBA-induced carcinoma
model [28].
 Reduction in serum levels of total sialic acid (TSA), lipid-bound sialic acid (LSA), prolactin, estradiol, progesterone,
serum TNFa, tissue caspase-3 activity, and DNA fragmentation [28].
 Amelioration of diethylnitrosamine-induced hepatocarcinogenesis [20].
 Induction of late-stage apoptosis and/or necrosis as well as inhibition of both DNA synthesis and cell proliferation
in HepG2 cells [21,32].
 Protection against diethylnitrosamine-induced hepatocellular adenoma [23].
 Reduction of serum AFP levels, relative liver weight, and activities of hexokinase, glyceraldehyde phosphate
dehydrogenase, and G6P dehydrogenase [31].
 Inhibition of the two-stage initiation/promotion of skin carcinogenesis and delays the onset of skin papilloma [25].
 Reduction of methylcholanthrene (MCA)-induced soft tissue sarcomas [25].
 Reduction in formation of pre-neoplastic lesions for colon cancer [27].
 Delay in mortality of P815 mastocytoma bearing cells [29].
Anti-oxidant and cytotoxic effects  Induction of cytotoxic effects against HepG2, MOLT4and LL/2 cells but no effects on normal cells [33].
 Induction of cytotoxic effects against MCF-7 cells [26].
 Induction of cytotoxic effects against EAC, DLA, S-180 cells [24].
 Induction of cytotoxic effects against SCL, SCL-6, SCL-3706, NUGC-4 cells [36].
 Reduction in expression of MDA and NO [34,41].
 Reduction in lipid peroxides and NO levels [28].
 No effect on not affect the level or catalytic activity of aspartate-aminotransferase, alanine-aminotransferase, and
gamma-glutamyltransferase [35].
 Amelioration of nephrotoxicity through reduction in creatinine and urea as well as elevation of GSH levels [37].
 Amelioration of anti-cancer drug-induced hepatic cytotoxicity [38].
 Amelioration of antibiotic-induced cytotoxicity in the thymus and spleen [39].
Anti-mutagenic effects  Inhibition against MNNG mutagenicity [43].
 Enhancement of DNA replication and reduction in chromosomal aberrations [43].
Anti-metastatic effects  Down regulation of t-PA, u-PA, and PAI-1 [44].
 Inhibition of liver metastasis [29].
Effects on NK cytotoxic activity  Enhancement of helper to suppressor T cell ratio and improvement of NK cytotoxic activity [46].
 Improvement and increase in cell numbers [48].
 Enhanced killing of YAC-1 tumor cells [50].
 Increase in production of IFNg and TNFa [49].
 Increase in production and activity of granzyme A and N-acetyl-b-D-glucosaminidase [49].
 Suppression of NK cytotoxic activity in CMV-infected mice [52].
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N. sativa is among the most commonly used herb in the history
of mankind. N. sativa is considered by many to be a “miracle” herb
due to its effective therapeutic potential to alleviate signs and
symptoms of many diseases including cancer. The anti-cancer
properties of N. sativa have been mainly attributed to its ability to
exert potent anti-proliferative, pro-apoptotic, anti-oxidant, anti-
mutagenic, and anti-metastatic roles. The protective effects of
N. sativa against tumor initiation and progression have also been
attributed, at least in part, to their ability to suppress inﬂammation
and exert immune-boosting effects. Enhancement of NK cytotoxic
activity against cancer cells and regulation of signaling pathways,
such as iNOS, p53, and caspases, mediate the potential of N. sativa
to subdue tumorigenesis and cancer. In vitro and in vivo experi-
mental ﬁndings suggest that N. sativa extracts can potentially be
employed in the development of effective therapeutic agents that
can be employed in the regulation of various stages of tumori-
genesis and treatment of many types of cancer. Further studies are
deﬁnitely needed to shed more light on the molecular and cellular
mechanisms underlying the anti-cancer effects of N. sativa. Such
research endeavors will hopefully elucidate the exact signaling
pathways implicated in the suppressive role that N. sativa extracts
play in tumorigenesis and cancer. Moreover, although the preclin-
ical, experimental evidence suggesting potent anti-cancer effects of
various N. sativa extracts is compelling, preventive and clinical
studies that directly point to the anti-cancer potential of N. sativa
extracts are still lacking. Future studies should focus on establishing
a direct link between the reported anti-cancer effects of N. sativaextracts and cancer prevention/treatment in preclinical and clinical
settings.
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